The buttocks have two distinct injection sites, and they are not equally safe. The ventrogluteal site, located on the upper side of the hip, is now widely considered the preferred location for intramuscular injections in adults. The dorsogluteal site, the traditional “upper outer quadrant” that most people picture when they think of a shot in the buttock, carries a higher risk of hitting the sciatic nerve or gluteal artery. Understanding the difference between these two sites, and how your body type influences which needle and technique will actually reach muscle, matters more than most people realize.
Two Sites, Not One
When someone says “a shot in the buttocks,” they could mean two very different anatomical locations. The dorsogluteal site sits on the large, fleshy part of the buttock, in the upper outer quadrant of the gluteus maximus. This is the spot that has been used for decades and remains the site many people default to. The ventrogluteal site is higher and more to the side, over the gluteus medius and minimus muscles near the hip bone. It sits forward of the dorsogluteal site and away from the major nerves and blood vessels that run through the deeper central buttock.
For the past two decades, clinical literature has consistently pointed to the ventrogluteal site as the safer option. A meta-analysis pooling data from multiple trials found that ventrogluteal injections produced less pain, less bleeding, and smaller hematomas compared to dorsogluteal injections.1PubMed Central. Adverse effects of dorsogluteal intramuscular injection versus ventrogluteal intramuscular injection: A systematic review and meta‐analysis Despite this evidence, surveys of nurses have found that roughly a third still frequently use the dorsogluteal site out of habit and training tradition.2PubMed Central. Creating a change in the use of ventrogluteal site for intramuscular injection
What Makes the Dorsogluteal Site Riskier
The sciatic nerve, the largest nerve in the body, runs through the middle of the gluteal region, typically passing deep to the piriformis muscle. When a dorsogluteal injection lands too far toward the center or too low, it can damage this nerve. The peroneal division of the sciatic nerve is especially vulnerable because of its position and the way it is tethered along its course.3PubMed Central. Iatrogenic Injury to the Sciatic Nerve due to Intramuscular Injection: A Case Report A misplaced injection can cause immediate, severe pain that shoots down the leg, along with numbness and weakness. In about one in ten cases of sciatic nerve injury, the symptoms are delayed by minutes to hours, making it harder to connect the injection to the damage.3PubMed Central. Iatrogenic Injury to the Sciatic Nerve due to Intramuscular Injection: A Case Report At the severe end, sciatic nerve injury from injection can cause lasting paralysis or a chronic pain condition that resists treatment.
Certain medications are more neurotoxic than others if they contact the nerve. A case report of a five-year-old child who received diclofenac (a common anti-inflammatory) into the left buttock documented motor weakness and loss of sensation in the leg afterward, with the peroneal division bearing the brunt of the injury.4Journal of Electrodiagnosis and Neuromuscular Diseases. Sciatic Nerve Injury after an Intramuscular Injection into the Gluteal Region The sciatic nerve can also follow variant paths around the piriformis muscle, meaning its exact location differs from person to person. This anatomical unpredictability is one more reason the dorsogluteal site carries inherent risk that careful landmarking can reduce but not eliminate.
The ventrogluteal site avoids these hazards. No major nerves or large blood vessels pass through it. The gluteus medius muscle there is thick and well-defined, providing a generous target that is easier to locate reliably with surface landmarks (the anterior superior iliac spine and the iliac crest).
How Body Composition Changes the Equation
Whether an intramuscular injection actually reaches muscle depends on how much subcutaneous fat lies between the skin surface and the muscle underneath. Gender, body mass index, and overall body shape all play a role. Women, people with higher BMIs, and those with rounder body shapes tend to have thicker subcutaneous fat at both gluteal sites, which increases the chance that a standard-length needle deposits medication into fat instead of muscle.5PubMed. Influence of gender, BMI and body shape on theoretical injection outcome at the ventrogluteal and dorsogluteal sites
Even with body composition factored in, the ventrogluteal site tends to perform better. A study in older adults found that the ventrogluteal site had thicker muscle and thinner subcutaneous tissue compared to the dorsogluteal site. Muscle thickness at the ventrogluteal site averaged about 40 mm versus roughly 26 mm at the dorsogluteal site, while subcutaneous fat was thinner at the ventrogluteal location.6PubMed. Examining the Safety of Dorsogluteal and Ventrogluteal Sites for Intramuscular Injection in Older Adults Both sites met the tissue-thickness thresholds generally considered acceptable for intramuscular injection, but the ventrogluteal site offered a bigger safety margin, with lower risk of bone contact and less chance of an inadvertent subcutaneous injection.
Needle Length Is Not One-Size-Fits-All
The standard needle for a gluteal intramuscular injection is typically 38 mm (1.5 inches), but that length is not adequate for everyone. Research has shown that a 38-mm needle fails to reach muscle in roughly seven out of ten women with a BMI above 30 and about six out of ten men with a BMI above 35 at the ventrogluteal site.7PubMed. Body Mass Index: A Reliable Predictor of Subcutaneous Fat Thickness and Needle Length for Ventral Gluteal Intramuscular Injections Those are striking failure rates for what many clinicians treat as the default equipment.
Recommended needle lengths vary widely depending on the individual. For ventrogluteal injections in women, published recommendations range from 20 mm in thin women to as long as 88 mm in obese women. For men, the range runs from about 18 mm to 82 mm.8Medical Research Archives. Intramuscular Injection Guideline Revisions are Needed Based on Body Mass Index, Needle Length, Sex, and Skin to Muscle Depth Studies measuring skinfold thickness at gluteal sites have confirmed that overweight and obese individuals of both sexes often need needles longer than the standard 25 mm (1 inch) to clear the subcutaneous layer.9PubMed. Prediction of optimal gluteal intramuscular needle length by skinfold thickness measurements in Korean adults
The practical takeaway is that clinicians should assess the injection site individually rather than reaching for the same needle for every patient. Weight, the visible amount of subcutaneous fat at the site, and the muscle mass underneath all matter. When the standard needle is too short, the medication ends up in fat tissue, which changes how quickly and completely it is absorbed and can lead to local complications.
When an Injection Lands in Fat Instead of Muscle
A medication deposited into subcutaneous fat instead of muscle does not just absorb more slowly. It can cause local tissue damage. A retrospective study of children who needed surgery for complications after buttock injections found that the overwhelming majority of complications developed within fat tissue rather than muscle. Acute inflammation, cellulitis, and abscess accounted for about 72% of cases, fat necrosis for about 22%, and injection granuloma for the remainder.10Journal of the Korean Association of Pediatric Surgeons. Local Complications after Intramuscular Injections in the Buttock in Children Nearly half the injections in that study had been placed outside the recommended upper outer quadrant, and Staphylococcus aureus was the predominant organism in abscesses.
Fat necrosis is a complication that often goes unrecognized. It presents as a firm, sometimes painful lump under the skin at the injection site, and it can be mistaken for a tumor on imaging.11PubMed Central. Fat necrosis: A neglected side effect of intramuscular injections In an era of rising obesity rates, some clinicians have raised the concern that standard needles are increasingly inadequate for gluteal injections, and that alternative sites or longer needles should be considered more routinely.12PubMed Central. Gluteal injections in increasingly obese population
Technique Matters as Much as Location
Choosing the right site and needle is only part of the equation. How the injection is performed affects both comfort and safety. The Z-track method is the most widely recommended technique for gluteal intramuscular injections. You use the non-injecting hand to pull the skin and fat layer to one side before inserting the needle, then release after withdrawal. This creates a zigzag path through the tissue that helps prevent the medication from leaking back along the needle track into the subcutaneous layer.13PubMed Central. A narrative review of the success of intramuscular gluteal injections and its impact in psychiatry
Positioning the person receiving the injection also makes a difference. Research on dorsogluteal injections found that internally rotating the thigh (turning the toes inward) relaxes the gluteus maximus, and injections into a relaxed muscle cause less discomfort than injections into a tense one.14PubMed. Effect of positioning on discomfort from intramuscular injections in the dorsogluteal site For ventrogluteal injections, having the person lie on their side with the top leg slightly bent and relaxed achieves a similar effect. Telling someone to “relax” rarely works; body positioning that physically prevents muscle contraction is more effective.
The Aspiration Debate
For decades, nurses and other clinicians were taught to pull back on the syringe plunger (aspirate) before injecting, checking for blood to make sure the needle had not entered a blood vessel. This practice is evolving. A systematic review concluded that aspiration is unnecessary at the ventrogluteal, deltoid, and vastus lateralis sites because no major blood vessels are present. However, the same review recommended continuing to aspirate at the dorsogluteal site because of its proximity to the gluteal artery.15PubMed. Aspirating during the intramuscular injection procedure: a systematic literature review
In practice, aspiration remains part of most nursing curricula and clinical guidelines worldwide, including those in the UK and several other countries.16F1000Research. Aspiration in injections: should we continue or abandon the practice? This is another area where the ventrogluteal site simplifies things. Because there are no large vessels in the area, clinicians using this site can skip aspiration entirely, which shortens the procedure and reduces patient discomfort. If you are administering or receiving an injection at the dorsogluteal site, aspiration remains a reasonable safety step.
How Much Can Be Injected at Once
The gluteal muscles can accommodate larger volumes than other injection sites. Up to 5 mL per injection has been reported as tolerable in adults at gluteal sites, compared with a usual maximum of about 2 mL for the deltoid (shoulder).17PubMed Central. Reply to Cossu et al., “Switching to deltoid intramuscular injections maintains therapeutic trough concentrations of rilpivirine and cabotegravir in people with HIV” This higher volume capacity is one reason the gluteal region is preferred for long-acting injectable medications, oil-based formulations, and drugs that require larger doses per injection.
That said, higher volumes tend to cause more post-injection soreness. Splitting a large dose across two sites rather than loading everything into one spot can reduce discomfort, and using the Z-track technique helps prevent backflow of the larger volume.
Drug Absorption Differs by Muscle Group
An often-overlooked consideration is that the gluteal muscles absorb drugs more slowly than the deltoid. Blood flow measurements have shown that resting blood flow in the deltoid is roughly 20% higher than in the gluteus, a difference large enough to affect how quickly a drug enters the bloodstream and what peak levels it reaches.18PubMed. Blood flow in muscle groups and drug absorption A study comparing diazepam absorption found that shoulder injections produced higher peak blood concentrations and faster sedation than thigh injections, consistent with the idea that muscles with better blood supply deliver drugs to the circulation faster.19PubMed. Absorption and sedative effects of diazepam after oral administration and intramuscular administration into the vastus lateralis muscle and the deltoid muscle
For some medications, slower absorption from the gluteal site is exactly what you want. Long-acting antipsychotics and hormonal injections, for instance, are designed to release gradually over weeks. The gluteal muscles’ lower blood flow rate actually helps sustain that slow release. For medications where rapid onset matters, the deltoid may be a better choice if the volume allows it.
Reducing Pain at the Injection Site
Pain is the most common complaint with gluteal injections, and a few evidence-based strategies can reduce it. Applying firm manual pressure to the injection site for about ten seconds before inserting the needle has been shown to lower pain scores by more than a third in controlled trials.20PubMed. Using pressure to decrease the pain of intramuscular injections The mechanism is straightforward: sustained pressure reduces the sensitivity of local pain receptors, so the needle prick registers less intensely.
Other practical approaches include warming oil-based medications to body temperature before injection, injecting slowly (particularly for volumes above 2 mL), and keeping the muscle relaxed through proper positioning. Choosing the ventrogluteal site over the dorsogluteal also helps on its own, as the meta-analysis discussed earlier confirmed lower pain scores at the ventrogluteal location.1PubMed Central. Adverse effects of dorsogluteal intramuscular injection versus ventrogluteal intramuscular injection: A systematic review and meta‐analysis
Why the Buttocks Are a Poor Choice for Infants and Small Children
The gluteal muscles are not well developed in infants and toddlers, which is why pediatric guidelines have long recommended against using the buttocks for injections in very young children. The vastus lateralis, on the front of the thigh, is the preferred site for infants because the muscle is relatively large and well-developed even in newborns, and it sits far from any major nerves.21American Academy of Pediatrics (Pediatrics). Intramuscular Injections in Infants and Small Children: A Preferred Site Selection
In the retrospective study of children with buttock injection complications, two-thirds of the patients were under two years old. The authors concluded that the small muscle mass and proportionally thicker subcutaneous fat layer in young children make it technically difficult to place a gluteal injection into muscle at all.10Journal of the Korean Association of Pediatric Surgeons. Local Complications after Intramuscular Injections in the Buttock in Children The combination of a small target and a child who may squirm during the injection significantly raises the odds of complications. For children old enough to have developed adequate gluteal muscle mass (typically school-age and older), the ventrogluteal site can be used, but the thigh remains a common and practical alternative.
Self-Injection Practicalities
Many people who give themselves regular injections, whether for hormone therapy, testosterone replacement, or other long-acting medications, use the gluteal region. Self-injection into the ventrogluteal site is possible but awkward. You need to locate the bony landmarks on your own hip while twisting to see the site, and maintaining the right angle can be difficult. The dorsogluteal site is easier to reach on yourself, which is one reason people continue using it despite its disadvantages.
If you self-inject into the dorsogluteal site, staying firmly in the upper outer quadrant is critical. A useful rule of thumb is to imagine the buttock divided into four equal quadrants and aim for the center of the upper outer one, staying well away from the midline and the lower half. Alternating sides from one injection to the next reduces the risk of tissue damage from repeated punctures in the same spot. And given the body-composition data on needle length, anyone with a higher BMI should have a conversation with their prescriber about whether a longer needle is warranted. The standard 1.5-inch needle that comes in most injection kits may not be reaching muscle.
Some self-injectors opt for the vastus lateralis (outer thigh) instead, which is much easier to see and reach. The trade-off is a smaller muscle volume, so it accommodates less medication per injection, and some people find thigh injections more painful than gluteal ones. The right choice depends on the medication, the volume, and what you can do comfortably and safely on your own.